{"id":"W3153071119","doi":"10.1038/s41523-021-00251-7","title":"Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Institute for Health and Care Research; Astex Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; AstraZeneca; National Cancer Institute; National Institutes of Health; Cancer Research UK; Breast Cancer Research Foundation","keywords":"Fulvestrant; PTEN; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Anastrozole; Cancer; Aromatase inhibitor; Cancer research; Estrogen receptor; PI3K/AKT/mTOR pathway; Biology; Aromatase; Signal transduction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001916187,0.0003942527,0.0004237906,0.0001371019,0.00007594695,0.00005136174,0.0001909889,0.0001792357,0.0002324092],"category_scores_gemma":[0.00002276041,0.0003720931,0.00009332137,0.0006444713,0.0001500138,0.00003284375,0.00007822329,0.000351836,0.000005240043],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000697564,"about_ca_system_score_gemma":0.001456692,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004627367,"about_ca_topic_score_gemma":0.01690862,"domain_scores_codex":[0.9975281,0.0002107199,0.0004136353,0.0008708821,0.0003751797,0.0006014284],"domain_scores_gemma":[0.9987625,0.0000309003,0.0001770138,0.000349628,0.0005222887,0.0001577063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002103702,0.0008245072,0.06496813,0.0001476697,0.0003551264,0.0003756418,0.0005463673,0.004209527,0.9120866,0.00006396313,0.0003973548,0.01392138],"study_design_scores_gemma":[0.00598568,0.0003026643,0.2681973,0.0008935498,0.0001316259,0.0004726997,0.0003933942,0.0005253923,0.7217966,0.0001052738,0.0003778109,0.0008179587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932514,0.002422903,0.0002737988,0.001733782,0.0003225156,0.0004787309,0.001271044,0.00002150665,0.0002243243],"genre_scores_gemma":[0.9977775,0.0002966049,0.0001706233,0.0006265066,0.000278648,0.0004699872,0.0001798245,0.00007195625,0.0001283055],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2032292,"threshold_uncertainty_score":0.9998731,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007119816247072573,"score_gpt":0.2537711970203723,"score_spread":0.2466513807732997,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}